ARCHIVES

ODAC Advice: Avoid ESAs In Curative Settings, Require Patients To Sign Informed Consent.

This article is from The Cancer Letter archive.

Vol. 34 No. 10 | March 14, 2008

Download PDF Visit The Full Archive

Related Articles

In Brief: Administration Ignores Congressional Mandate To Revive Training Grants, Funds Fellowships

February 8, 1974

Budesonide Not Beneficial For Diarrhea In Melanoma

August 28, 2009

Univ. Of Alabama Resident to Be New HEW Secretary

June 20, 1975

Accrediting Agency Places Dana-Farber On Probation

April 21, 1995

NCI-Approved Cancer Center, Cooperative Group Trials

December 28, 2007

FDA Approval Of Two Generic Versions Of Taxol Likely To End BMS Exclusivity.

September 29, 2000